ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Chang S. Chan(Rutgers, The State University of New Jersey), Saurabh V. Laddha(Rutgers, The State University of New Jersey), Peter W. Lewis(University of Wisconsin–Madison), Matthew S. Koletsky(Rockefeller University), Kenneth Robzyk(Memorial Sloan Kettering Cancer Center), Edaise da Silva(Memorial Sloan Kettering Cancer Center), Paula J. Torres(Memorial Sloan Kettering Cancer Center), Brian R. Untch(Memorial Sloan Kettering Cancer Center), Janet Li(Memorial Sloan Kettering Cancer Center), Promita Bose(Memorial Sloan Kettering Cancer Center), Timothy A. Chan(Memorial Sloan Kettering Cancer Center), David S. Klimstra(Memorial Sloan Kettering Cancer Center), C. David Allis(Rockefeller University), Laura H. Tang(Memorial Sloan Kettering Cancer Center)
Nature Communications
October 2, 2018
Cited by 228Open Access
Full Text

Abstract

The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis to reveal two distinct subgroups with one consisting entirely of A-D-M mutant PanNETs. Two genes differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha-cells (FDR q-value < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells.


Related Papers

No related papers found

Powered by citation graph analysis